Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,138.26
(
-0.50%
)
US TECH 100
26,326.00
(
-0.92%
)
Dow Jones
49,112.85
(
-0.40%
)
Brent Oil
104.38
(
2.22%
)
Bitcoin
76,165.32
(
-1.56%
)
News Focus
News Focus
Post# of 257458
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122897
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: dewophile post# 252765

Thursday, 11/07/2024 11:17:48 AM

Thursday, November 07, 2024 11:17:48 AM

Post# of 257458
MRNA 3Q24 mResvia—(RSV vaccine)—sales—>paltry $10M:

https://finance.yahoo.com/news/moderna-reports-third-quarter-2024-113000187.html

The Company reported $10 million in mRESVIA sales in the third quarter of 2024. Sales were lower than anticipated, resulting from the approval and recommendation of mRESVIA later in the contracting season, when many customers had completed their orders.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now